Pharmacology of Analgesics

Anesthesia and Analgesia in Laboratory Animals

Volumn , Issue , 2008, Pages 97-123

  Heavner, James E ^a   Cooper, Dale M ^b  

^a TEXAS TECH UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884087220     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373898-1.50008-5     Document Type: Chapter

References (183)

1. 28:08 central nervous system agents. AHFS Drug Information 2007, American Hospital Formulary Service, American Society of Health-System Pharmacists, Inc., Bethesda, MD. G.K. McEvoy (Ed.).
2. Archer B.P., Erven A., Roth S.H., Samanani N. Plasma, brain and spinal cord concentrations of thiopental associated with hyperanalgesia in the rat. Anesthesiology 1994, 80:168-176.
3. Arifah A.K., Landoni M.F., Frean S.P., Lees P. Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep. Am. J. Vet. Res. 2001, 62:77-96.
4. Arifah A.K., Landoni M.F., Lees P. Pharmacodynamics, chiral pharmacokinetics and PK-PD modeling of ketoprofen the goat. J. Vet. Pharmacol. Ther. 2003, 26:139-150.
5. Armstrong S., Tricklebank P., Lake A., Frean S., Lees P. Pharmacokinetics of carprofen enantiomers in equine plasma and synovial fluid-A comparison with ketoprofen. J. Vet. Pharmacol. Ther. 1999, 22:196-201.
6. Avsaroglu H., Versluis A., Hellebrekers L.J., Haberham Z.L., van Zutphen L.F.M., van Lith H.A. Strain differences in response to propofol, ketamine and medetomidine in rabbits. Vet. Rec. 2003, 152:300.
7. Ayoub S.S., Botting R.M., Goorha S., Colville-Nash P.R., Willoughby D.A., Ballou L.R. Acetaminophne-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11165-11169.
8. Baert K., De Backer P. Disposition of sodium salicylate, flunixin and meloxicam after intravenous administration in broiler chickens. J. Vet. Pharmacol. Ther. 2002, 25:449-453.
9. Baggot J.D. Clinical pharmacokinetics in veterinary medicine. Clin. Pharmocinet. 1992, 22:254-273.
10. Bauer D.J., Christenson B.A., Clark K.R., Powell S.K., Swain R.A. Acetaminophen as a postsurgical analgesic in rats: a practical solution to neophobia. Coutemp. Top. Lab. Auim. Sci. 2003, 42(2):20-25.
11. Bayer B.M., Daussin S., Hernandez M., Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 1990, 29:369-374.
12. Benton H.P., Vasseur P.B., Broderick-Villa G.A., Koolpe M. Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin release by cultured osteoarthritic canine chondrocytes. Am. J. Vet. Res. 1997, 58:286-292.
13. 2-adrenergic receptors. Life Sci. 1977, 21:596.
14. Brideau C., Van Staden C., Chan C.C. In vitro effects of cyclooxy-genase inhibitors in whole blood of horses, dogs, and cats. Am. J. Vet. Res. 2001, 62:1755-1760.
15. Brune K., Zeilhofer H.U. Antipyretic (non-narcotic) analgesics. Textbook of Pain 1999, 1139-1153. Churchill Livingstone, Edinburgh. P.D. Wall, R. Melzack (Eds.).
16. Bryant C.E., Farnfield B.A., Janicke H.J. Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B. Am. J. Vet. Res. 2003, 64:211-215.
17. Bulka A., Kouya P.F., Bottiger Y., Svensson J.O., Xu X.J., Wiesenfeld-Hallin Z. Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats. Ear. J. Pharmacol. 2004, 492:27-34.
18. Bussiere J.L., Adler M.W., Rogers T.J., Eisenstein T.K. Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacol. Immunotoxicol. 1992, 14:657-673.
19. Buur J.L., Baynes R.E., Smith G., Riviere J.E. Pharmacokinetics of flunixin meglumine in swine after intravenous dosing. J. Vet. Pharmacol. Ther. 2006, 29:437-440.
20. Capetola R.J., Rosenthale M.E., Dubinsky B., McGuire J.L. Peripheral antialgesics: A review. J. Clin. Pharmacol. 1983, 23:545-556.
21. Capuano S.V., Lerche N.W., Valverde C.R. Cardiovascular, respiratory, thermoregulatory, sedative, and analgesic effects of intravenous administration of medetomidine in rhesus macaques ( Macaca mulatta). Lab. Anim. Sci. 1999, 49:537-544.
22. Carr D.J.J., France C.P. Immune alterations in morphine-treated rhesus monkeys. J. Pharmacol. Exp. Ther. 1993, 267:9-15.
23. Carroll G.L., Hartsfield S.M., Champney T.H., Geller S.C., Martinez E.A., Haley E.L. Effect of medetomidine and its antagonism with atipamezole on stress-related hormones, metabolites, physiologic responses, sedation, and mechanical threshold in goats. Vet. Anaesth. Analg. 2005, 32:147-157.
24. Carroll G.L., Hooper R.N., Boothe D.M., Hartsfield S.M., Randoll L.A. Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats. Am. J. Vet. Res. 1999, 60:986-991.
25. Cheng Z., McKellar Q., Nolan A. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep. J. Vet. Pharmacol. Ther. 1998, 21:315-321.
26. Cheng Z., Nolan A., McKellar Q.A. Anti-inflammatory effects of carprofen, carprofen enantiomers, and N(G)-nitro- L-arginine methyl ester in sheep. Am. J. Vet. Res. 2002, 63:782-788.
27. Cheng Z., Nolan A., Montiero A., McKellar Q.A. Enantioselective pharmacokinetics and cyclooxygenase inhibition of carprofen and carprofen enantiomers in sheep. J. Vet. Pharmacol. Ther. 2003, 26:391-394.
28. Ciofalo V.B., Latranyi M.B., Patel J.B., Taber R.I. Flunixin meglumine: A non-narcotic analgesic. J. Pharmacol. Ther. 1977, 200:501-507.
29. Clark M.D., Krugner-Higby L., Smith L.J., Heath T.D., Clark K.L., Olson D. Evaluation of liposome-encapsulated oxymorphone hydrochloride in mice after splenectomy. Comp. Med. 2004, 54:558-563.
30. Clark T.P. The clinical pharmacology of cyclooxygenase-2-selective and dual inhibitors. Vet. Clin. N. Am. Small Anim. Pract. 2006, 36:1061-1085.
31. Coakley M., Peck K.E., Taylor T.S., Matthews N.S., Mealey K.L. Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses. Am. J. Vet. Res. 1999, 60:1441-1444.
32. Cooper D.M., DeLong D., Gillett C.S. Analgesic efficacy of acetaminophen and buprenorphine administered in the drinking water of rats. Coutemp. Top. Lab. Auim. Sci. 1997, 36:58-62.
33. Cooper D.M., Hoffman W., Wheat N., Lee H. Duration of effects on clinical parameters and referred hyperalgesia in rats after abdominal surgery and multiple doses of analgesic. Comp. Med. 2005, 55:344-353.
34. Cooper S.A., Reynolds D.C., Reynolds B., Hersh E.V. Analgesic efficacy and safety of ( R)-ketoprofen in post-operative dental pain. J. Clin. Pharmacol. 1998, 38:11S-18S.
35. Copland V.S., Haskins S.C., Patz J. Naloxone reversal of oxymorphone effects in dogs. Am. J. Vet. Res. 1989, 50:1854-1858.
36. Corvelyn S., Deprez P., Van der Weken G., Baeyens W., Remon J.P. Bioavailability of ketoprofen in horses after rectal administration. J. Vet. Pharmacol. Ther. 1996, 19:359-363.
37. Court M.H., Dodman N.H., Levine H.D., Richey M.T., Lee J.W., Hustead D.R. Pharmacokinetics and milk residues of butorphanol in dairy cows after single intravenous administration. J. Vet. Pharmacol. Ther. 1992, 15:29-35.
38. Cousins M., Power I. Acute and postoperative pain. Textbook of Pain 1999, 447-491. Churchill Livingstone, Edinburgh. 4th ed. P.D. Wall, R. Melzack (Eds.).
39. Cui J.G., Kuiroda H., Chandrasekharan N.V., Pelaez R.P., Simmons D.L., Bazan N.G., Lukiw W.J. Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells. Neurochem. Res. 2004, 29:1731-1737.
40. Czlonkowski A., Stein C., Herz A. Peripheral mechanisms of opioid antinociception in inflammation: Involvement of cytokines. Ear. J. Pharmacol. 1993, 242:299-335.
41. Dahan A., Yassen A., Bijl H., Romberg R., Sarton E., Teppema L., Olofsen E., Danhof M. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br. J. Anaesth. 2005, 94:825-834.
42. Danbury T.C., Weeks C.A., Chambers J.P., Waterman-Pearson A.E., Kestin S.C. Self-selection of the analgesic drug carprofen by lame broiler chickens. Vet. Rec. 2000, 146:307-311.
43. Dascombe M.J. The pharmacology of fever. Prog. Neurobiol. 1985, 25:327-373.
44. Davies N.M., Wright M.R., Russell A.S., Jamali E. Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability. J. Pharm. Sci. 1996, 85:1170-1173.
45. Davis L.E. Species differences in drug disposition as factors in alleviation of pain. Animal Pain: Perception and Alleviation 1983, 161-178. American Physical Society, Bethesda, MD. R.L. Kitchell, H.H. Erickson (Eds.).
46. Davis L.E., Westfall B.A. Species differences in the biotransformation excretion of salicylate. Am. J. Vet. Res. 1972, 33:1253-1262.
47. Delatour P., Foot R., Foster A.P., Baggot D., Lees P. Pharmacodynamics and chiral pharmacokinetics of carprofen in calves. Br. Vet. J. 1996, 152:183-198.
48. Diaz-Reval M.I., Ventura-Martinez R., Deciga-Campos M., Terron J.A., Cabre F., Lopez-Munoz F.J. Evidence for a central mechanism of action of S-(+)-ketoprofen. Eur. J. Pharmacol. 2004, 483:241-248.
49. Difilippo S.M., Norberg P.J., Suson U.D., Savino A.M., Reim D.A. A comparison of xylazine and medetomidine in an anesthetic combination in New Zealand white rabbits. Contemp. Top. Lab. Anim. Sci. 2004, 43(1):32-34.
50. Dobbins S., Brown N.O., Shofer F.S. Comparison of the effects of buprenorphine, oxymorphone hydrochloride, and ketoprofen for postoperative analgesia after onychectomy or onychectomy and sterilization in cats. J. Am. Anim. Hosp. Assoc. 2002, 38:507-514.
51. Dum J.E., Herz A. In vivo receptor binding of the opiate partial agonist buprenorphine, correlated with its agonistic and antagonistic actions. Br. J. Pharmacol. 1981, 74:627-633.
52. Egger C.M., Duke T., Archer J., Cribb P.H. Comparison of plasma fentanyl concentrations by using three transdermal fentanyl patch sizes in dogs. Vet. Surg. 1998, 27:159-166.
53. 2adrenergic mechanisms of spinal anesthesia. Reg. Anesth. 1993, 18:i-vi.
54. Elmas M., Yazar E., Uney K., Karabacak A. Pharmacokinetics of flunixin after intravenous administration in healthy and endotoxaemic rabbits. Vet. Res. Commun. 2006, 30:73-81.
55. Flecknell P.A. Post-operative analgesia in rabbits and rodents. Lab. Anim. 1991, 20:34-37.
56. Forsyth S.F., Guilford W.G., Pfeiffer D.U. Effect of NSAID administration on creatinine clearance in healthy dogs undergoing anaesthesia and surgery. J. Small Anim. Pract. 2000, 41:547-550.
57. Fuchs B.A., Pruett S.B. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: Involvement of both opiate and glucocorticoid receptors. J. Pharmacol. Exp. Ther. 1993, 266:417-423.
58. Gades N.M., Danneman P.J., Wixson S.K., Tolley E.A. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Coutemp. Top. Lab. Auim. Sci. 2000, 39(2):8-13.
59. Garrett E.R., Chandran V.R. Pharmacokinetics of morphine and its surrogates VI: Bioanalysis, solvolysis kinetics, solubility, pK'a values, and protein binding of buprenorphine. J. Pharm. Sci. 1985, 74:515-524.
60. Garrido M.J., Sayar O., Segura C., Rapado J., Dios-Vieitez M.C., Renedo M.J., Troconiz I.F. Pharmacokinetic/pharmacodynamic modeling of the antinociceptive effects of (+)-tramadol in the rat: Role of cytochrome P450 2D activity. J. Pharmacol. Exp. Ther. 2003, 305:710-718.
61. Gilberto D.B., Motzel S.L., Das S.R. Postoperative pain management using fentanyl patches in dogs. Contemp. Top. Lab. Anim. Sci. 2003, 42(4):21-36.
62. Gillingham M.B., Clark M.D., Dahly E.M., Krugner-Higby L.A., Ney D.M. A comparison of two opioid analgesics for relief of visceral pain induced by intestinal resection in rats. Contemp. Top. Lab. Anim. Sci. 2001, 40(1):21-26.
63. Graf P., Glatt M., Brune K. Acidic nonsteroidal anti-inflammatory drugs accumulating in inflamed tissue. Experientia 1975, 31:951-954.
64. Graham J.E., Kollias-Baker C., Craigmill A.L., Thomasy S.M., Tell L.A. Pharmacokinetics of ketoprofen in Japanese Quail (Coturnix japonica). J. Vet. Pharmacol. Ther. 2005, 28:399-402.
65. Gutstein H.B., Akil H. Opioid analgesics. Goodman & Gilman's The Pharmacological Basis of Therapeutics 2001, 569-619. McGraw-Hill, New York. 10th ed. J.G. Hardman, L.E. Limbird (Eds.).
66. Hall L.W., Clarke K.W. Principles of sedation. Veterinary Anaesthesia 1991, 58. Baillière Tindall, London. 9th ed.
67. Hardie E.M., Hardee G.E., Rawlings C.A. Pharmacokinetics of flunixin meglumine in dogs. Am. J. Vet. Res. 1985, 46:235-237.
68. Heel R.C., Brogden R.N., Speight T.M., Avery G.S. Buprenorphine: A review of its pharmacological properties and therapeutic efficacy. Drugs. 1977, 17:81-110.
69. Hickford F.H., Barr S.C., Erb H.N. Effect of carprofen on hemostatic variables in dogs. Am. J. Vet. Res. 2001, 62:1642-1646.
70. Horii Y., Ikenaga M., Shimoda M., Kokue E. Pharmacokinetics of flunixin in the cat: Enterohepatic circulation and active transport mechanism in the liver. J. Vet. Pharmacol. Ther. 2004, 27:65-69.
71. Hosgood G. Pharmacologic features ofbutorphanol in dogs and cats. J. Am. Vet. Med. Assoc. 1990, 196:135-136.
72. Hsu W.H., Lee P., Betts D.M. Xylazine-induced mydriasis in rats and its antagonism by alpha-adrenergic blocking agents. J. Vet. Pharmacol. Ther. 1981, 4:97-101.
73. Hsu W.S. Xylazine-induced depression and its antagonism by u2adrenergic blocking agents. J. Pharmacol. Exp. Ther. 1981, 218:188.
74. Hug C.C., Murphy M.R. Tissue redistribution of fentanyl and termination of its effects in rats. Anesthesiology 1981, 55:369-375.
75. Hughes H.C., Lang C.M. Control of pain in dogs and cats. Animal Pain: Perception and Alleviation 1983, 207-216. American Physiological Society, Bethesda, MD. R.L. Kitchell, H.H. Erickson (Eds.).
76. Hunter R.P., Isaza R., Carpenter J.W., Koch D.E. Clinical effects and plasma concentrations of fentanyl after transmucosal administration in three species of great ape. J. Zoo Wildl. Med. 2004, 35:162-166.
77. Hussain M.A., Aungst B.J. Intranasal absorption ofoxymorphone. J. Pharm. Sci. 1997, 86:975-976.
78. Hutchings D.E., Zmitrovich C., Hamowy A.S., Liu P.R. Prenatal administration of buprenorphine using the osmotic minipump: A preliminary study of maternal and offspring toxicity and growth in the rat. Neurotoxicol. Teratol. 1995, 17:419-423.
79. Igarza L., Soraci A., Auza N., Zeballos H. Some pharmacokinetic parameters of R-(-)- and S-(+)-ketoprofen: The influence of age and differing physiological status in dairy cattle. Vet. Res. Com. 2004, 28:81-87.
80. Insel P.A. Analgesic-antipyretics and antiinflammatory agents: Drugs employed in the treatment of rheumatoid arthritis and gout. The Pharmacological Basis of Therapeutics 1990, 63-81. Pergamon, New York. 8th ed. A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.).
81. Irazuzta J.E., Ahmed U., Gancayco A., Ahmed S.T., Zhang J., Anand K.J. Intratracheal administration of fentanyl: Pharmacokinetics and local tissue effects. Intensive Care Med. 1996, 22:129-133.
82. Itamoto K., Taura Y., Wada N., Taga A., Takuma T., Matsumura H., Miyara T. Effect of medetomidine on electroencephalography and use of a quantitative electroencephalograph for evaluating sedation levels in dogs. J. Yet. Med. Ser. A. 2001, 48:525-535.
83. Iwakawa S., Spahn H., Benet L.Z., Lin E.T. Stereoselective disposition of carprofen, flunoxaprofen, and naproxen in rats. Drug Metab. Disp. 1991, 19:853-857.
84. Jablonski P., Howden B.O., Baxter K. Influence of buprenorphine analgesia on post-operative recovery in two strains of rats. Lab. Anim. 2000, 35:213-222.
85. Jaffe J.H., Martin W.R. Opioid analgesics and antagonists. The Pharmacological Basis of Therapeutics 1990, 485-521. Pergamon, New York. 8th ed. A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.).
86. Joy R.M., Stark L.G., Albertson T.E. Dose-dependent proconvulsant and anticonvulsant actions of the alpha 2 adrenergic agonist, xylazine, on kindled seizures in the rat. Pharmacol. Biochem. Behav. 1983, 19:345-350.
87. Kastner S.B.R., Pakarinen S.M., Ramela M.P., Kutter A.P.N., Boller J., Huhtinen M.K. Comparative pharmacokinetics of medetomidine enantiomers in goats and sheep during sevoflurane anaesthesia. J. Vet. Pharmacol. Ther. 2006, 29:63-66.
88. Kastner S.B.R., Wapf P., Feige K., Demuth D., Bettschart-Wolfensberger R., Akens M.K., Huhtinen M. Pharmacokinetics and sedative effects of intramuscular medetomidine in domestic sheep. J. Vet. Pharmacol. Ther. 2003, 26:271-276.
89. Kirchner T., Aparico B., Argentieri D.C., Lau C.Y., Ritchie D.M. Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation. Prostaglandins Leukot. Essent. Fatty Acids 1997, 56:417-423.
90. Kis B., Snipes J.A., Busija D.W. Acetaminophen and the cyclooxygenase-3 puzzle: Sorting out facts, fictions, and uncertainties. J. Pharmacol. Exp. Ther. 2005, 315:1-7.
91. Konigsson K., Torneke K., Engeland I.V., Odensvik K., Kindahl H. Pharmacokinetics and pharmacodynamic effects of flunixin after intravenous, intramuscular and oral administration to dairy goats. Acta Vet. Scand. 2003, 44:153-159.
92. Kostopanagiotou G., Markantonis S.L., Arkadopoulos N., Andreadou I., Charalambidis G., Chondroudaki J., Costopanagiotou C., Smyrniotis V. The effect of acutely induced hepatic failure on remifentanil and fentanyl blood levels in a pig model. Ear. J. Anaesthesiol. 2006, 23:598-604.
93. 2 in a rat postoperative pain model. Anesth. Pharmacol. 2006, 103:334-343.
94. Krugner-Higby L., Smith L., Clark M., Heath T.D., Dahly E., Schiffman B., Hubbard-VanStelle S., Ney D., Wendland A. Liposome-encapsulated oxymorphone hydrochloride provides prolonged relief of postsurgical visceral pain in rats. Comp. Med. 2003, 53:270-279.
95. Kucuk A., Kadioglu Y., Celebi F. Investigation of the pharmacokinetics and determination of tramadol in rabbit plasma by a high-performance liquid chromatography-diode array detector method using liquid-liquid extraction. J. Chromatogr B. Analyt. Technol. Biomed. Life. Sci. 2005, 816:203-208.
96. KuKanich B., Papich M.G. Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs. J. Vet. Pharmacol. Ther. 2004, 27:239-246.
97. Lamont L.A., Bulmer B.J., Grimm K.A., Tranquilli W.J., Sisson D.D. Cardiopulmonary evaluation ofthe use of medetomidine hydrochloride in cats. Am. J. Vet. Res. 2001, 62:1745-1749.
98. Landoni M.F., Cunningham F.M., Lees P. Pharmacokinitics and pharmacodynamics of ketoprofen in calves applying PK/PD modeling. J. Vet. Pharmacol. Ther. 1995, 18:315-324.
99. Laredo F.G., Belda E., Murciano J., Escobar M., Navarro A., Robinson K.J., Jones R.S. Comparison of the analgesic effects of meloxicam and carprofen administered preoperatively to dogs undergoing orthopaedic surgery. Vet. Rec. 2004, 155:667-671.
100. Lascelles B.D., Robertson S.A. Antinociceptive effects of hydromorphone, butorphanol, or the combination in cats. J. Vet. Intern. Med. 2004, 18:190-195.
101. Lee D.D., Papich M.G., Hardie E.M. Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats. Am. J. Vet. Res. 2000, 61:672-677.
102. Lees P., Aliabadi F.S., Landoni M.F. Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the horse. J. Vet. Pharmacol. Ther. 2002, 25:443-448.
103. Lees P., Taylor P.M., Landoni F.M., Arifah A.K., Waters C. Ketoprofen in the cat: Pharmacodynamics and chiral pharmacokinetics. Vet. J. 2003, 161:21-35.
104. Lemke K.A. Perioperative use of selective alpha-2 agonists and antagonists in small animals. Can. Vet. J. 2004, 45:475-480.
105. Levier D.G., Brown R.D., McCay J.A., Fuchs B.A., Harris L.S., Munson A.E. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets. J. Pharmacol. Exp. Ther. 1993, 267:357-363.
106. Levoin N., Blondeau C., Guillaume C., Grandcolas L., Chretien F., Jouzeau J.Y., Benoit E., Chapleur Y., Netter P., Lapicque F. Elucidation of the mechanism of inhibition of cyclooxygenases by acyl-coenzyme A and acylglucuronic conjugates of ketoprofen. Biochem. Pharmacol. 2004, 68:1957-1969.
107. Liles J.H., Flecknell P.A. The effects of buprenorphine, nalbuphine and butorphanol alone or following halothane anesthesia on food and water consumption and locomotor movement in rats. Lab. Anim. 1992, 26:180-189.
108. Lobetti R.G., Joubert K.E. Effect of administration of nonsteroidal anti-inflammatory drugs before surgery on renal function in clinically normal dogs. Am. J. Vet. Res. 2000, 61:1501-1507.
109. Lohuis J.A., van Werven T., Brand A., van Miert A.S., Rohde E., Ludwig B., Heizmann P., Rehm W.F. Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis. J. Vet. Pharmacol. Ther. 1991, 14:219-229.
110. Ludwig B., Jordan J.C., Rehm W.F., Thun R. Carprofen in veterinary medicine. I. Plasma disposition, milk excretion and tolerance in milk-producing cows. Schweiz. Arch. Tierheilkd. 1989, 131:99-106.
111. 2-adrenoceptor agonists used as veterinary sedatives. Animal Pain 1992, 181-191. Churchill-Livingstone, New York. C.E. Short, A. Van Poznak (Eds.).
112. MacDonald E., Virtanen R. The effects of buprenorphine, nalbuphine and butorphanol alone or following halothane anesthesia on food and water consumption and locomotor movement in rats. Lab. Anim. 1992, 26:180-189.
113. Machado C.E., Dyson D.H., Grant Maxie M. Effects of oxymorphone and hydromorphone on the minimum alveolar concentration of isoflurane in dogs. Vet. Anaesth. Analg. 2006, 33:70-77.
114. Machin K.L., Tellier L.A., Lair S., Livingston A. Pharmacodynamics of flunixin and ketoprofen in mallard ducks ( Anas platyrhynchos). J. Zoo Wildl. Med. 2001, 32:222-229.
115. Maire-Gauthier R., Buronfosse T., Magdalou J., Herber R., Besse S., Delatour P., Benoit E. Species-dependent enantioselective glucuronidation of carprofen. Xenobiotica 1998, 28:595-604.
116. Malmberg A.B., Yaksh T.L. Pharmacology of the spinal action of ketorolac, morphine, ST-9 1, U50488H, and LPIA on the formalin test and an isobolographic analysis ofthe NSAID interaction. Anesthesiology 1993, 79:270-281.
117. Mathews K.A., Paley D.M., Foster R.A., Valliant A.E., Young S.S. A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs. Can. Yet. J. 1996, 37:557-567.
118. Mauleon D., Mis R., Ginesta J., Ortega E., Vilageliu J., Basi N., Carganico G. Pharmacokinetics of ketoprofen enantiomers in monkeys following single and multiple oral administration. Chirality 1994, 6:537-542.
119. Maxwell L.K., Thomasy S.M., Slovis N., Kollias-Baker C. Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses. Equine Vet. J. 2003, 35:484-490.
120. McClain R.M., Hoar R.M. Reproduction studies with carprofen, a nonsteroidal anti-inflammatory agent in rats. Toxicol. Appl. Pharmacol. 1980, 56:376-382.
121. Classification of Chronic Pain 1994, 210. IASP Press, Seattle, WA. 2nd ed. H. Merskey, N. Bogduk (Eds.).
122. Meunier C.J., Verbeeck R.K. Glucuronidation kinetics of R, S-ketoprofen in adjuvant-induced arthritic rats. Pharm. Res. 1999, 16:1081-1086.
123. Mickley G.A., Hoxha Z., Biada J.M., Kenmuir C.L., Bacik S.E. Acetaminophen self-administered in the drinking water increases the pain threshold of rats ( Rattus norvegicus). J. Am. Assoc. Lab. Anim. Sci. 2006, 45:48-54.
124. Molina C., Herrero J.F. The influence of the time course of inflammation and spinalization on the antinociceptive activity of the a2-adrenoceptor agonist medetomidine. Ear. J. Pharmacol. 2006, 532:50-60.
125. Montoya L., Ambros L., Kreil V., Bonafine R., Albarellos G., Hallu R., Soraci A. A pharmacokinetic comparison of meloxicam and ketoprofen following oral administration to healthy dogs. Vet. Res. Commun. 2004, 28:415-428.
126. Novick D.M., Ochshorn M., Ghali V., Croxson T.S., Mercer W.D., Chiorazzi N., Kreek M.J. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther. 1989, 250:606-610.
127. Ogino T., Mizuno Y., Ogata T., Takahashi Y. Pharmacokinetic interactions of flunixin meglumine and enrofloxacin in dogs. Am. J. Vet. Res. 2005, 66:1209-1213.
128. Ogiso T., Kitagawa T., Iwaki M., Tanino T. Pharmacokinetic analysis of enterohepatic circulation of etodolac and effect of hepatic and renal injury on the pharmacokinetics. Biol. Pharm. Bull. 1997, 20:405-410.
129. Ohtani M., Kotaki H., Uchino K., Sawada Y., Iga T. Pharmacokinetic analysis ofenterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats. Drug Metab. Dispos. 1994, 22:2-7.
130. Ota S., Bamba H., Kato A., Kawamoto C., Yoshida Y., Fujiwara K. Review article: COX-2, prostanoids and colon cancer. Aliment. Pharmacol. Ther. 2002, 16(Suppl. 2):102-106.
131. Palylyk-Colwell E.L., Jamali F. Effect of gonadectomy and hormones on sex differences in ketoprofen enantiomer glucuronidation and renal excretion of formed glucuronides in the rat. Pharm. Res. 2004, 21:989-995.
132. Peckham E.M., Traynor J.R. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J. Pharmacol. Exp. Ther. 2006, 316:1195-1201.
133. Pibarot P., Dupuis J., Grisneaux E., Cuvelliez S., Plante J., Beauregard G., Bonneau N.H., Bouffard J., Blais D. Comparison of ketoprofen, oxymorphone hydrochloride, and butorphanol in the treatment of postoperative pain in dogs. J. Am. Vet. Med. Assoc. 1997, 211:438-444.
134. Pinardi G., Sierralta F., Miranda H.F. Interaction between the antinociceptive effect of ketoprofen and adrenergic modulatory systems. Inflammation 2001, 25:233-239.
135. Portnoy L.G., Hustead D.R. Pharmacokinetics of butorphanol tartrate in rabbits. Am. J. Vet. Res. 1992, 53:541-543.
136. Power I. Recent advances in postoperative pain therapy. Br. J. Anaesth. 2005, 95:43-51.
137. Pruett S.B., Han Y.C., Fuchs B.A. Morphine suppresses primary humoral immune responses by a predominately indirect mechanism. J. Pharmacol. Exp. Ther. 1992, 262:923-928.
138. Quimby F.W. Pain in animals and humans: An introduction. ILAR News 1991, 33:2-3.
139. Roberts L.J., Morrow J.D. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. Goodman & Gilman's The Pharmacological Basis of Therapeutics 2001, 687-731. McGraw-Hill, New York. 10th ed. J.G. Hardman, L.E. Limbird (Eds.).
140. Robertson S.A., Taylor P.M., Lascelles B.D., Dixon M.J. Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine. Vet. Rec. 2003, 153:462-465.
141. Robertson S.A., Taylor P.M., Sear J.W., Keuhnel G. Relationship between plasma concentrations and analgesia after intravenous fentanyl and disposition after other routes of administration in cats. J. Vet. Pharmacol. Ther. 2005, 28:87-93.
142. Robinson E.P., Faggella A.M., Henry D.P., Russell W.L. Comparison of histamine release induced by morphine and oxymorphone administration in dogs. Am. J. Vet. Res. 1988, 49:1699-1701.
143. 2-terminal serine of prostaglandin synthetase by aspirin. J. Biol. Chem. 1978, 253:3782-3784.
144. Roughan J.V., Flecknell P.A. Buprenorphine: A reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals. Lab. Anim. 2002, 36:322-343.
145. Roughan J.V., Flecknell P.A. Behaviour-based assessment of the duration of laparotomy-induced abdominal pain and the analgesic effects of carprofen and buprenorphine in rats. Behav. Pharmacol. 2004, 15:461-472.
146. Sano T., Nishimura R., Kanazawa H., Igarashi E., Nagata Y., Mochizuki M., Sasaki N. Pharmacokinetics of fentanyl after single intravenous injection and constant rate infusion in dogs. Vet. Anaesth. Analg. 2006, 33:266-273.
147. Saper C.B., Breder C.D. The neurologic basis of fever. N. Engl. J. Med. 1994, 330:1880-1886.
148. Satterwhite J.H., Boudinot F.D. Pharmacokinetics of ketoprofen in rats: Effect of age and dose. Biopharm. Drug Dispos. 1992, 13:197-212.
149. 2-adrenoceptors. J. Auton. Pharmacol. 1986, 5:275-284.
150. Schmitt M., Gentert T.W. Biopharmaceutical evaluation of carprofen following intravenous, oral, and rectal administration in dogs. Biopharm. Drug Dispos. 1990, 11:585-594.
151. Schmitt M., Gentert T.W. Biopharmaceutical evaluation of ketoprofen following intravenous, oral, and rectal administration in dogs. J. Pharm. Sci. 1990, 79:614-616.
152. Schoemaker N.J., Mol J.A., Lumeij J.T., Thijssen J.H.H., Rijnberk A. Effects of anaesthesia and manual restraint on the plasma concentrations of pituitary and adrenocortical hormones in ferrets. Vet. Rec. 2003, 152:591-595.
153. Shannon H. Personal communication 2007.
154. Sharp J., Zammit T., Azar T., Lawson D. Recovery of male rats from major abdominal surgery after treatment with various analgesics. Contemp. Top. Lab. Anim. Sci. 2003, 42(6):22-27.
155. Shavit Y., Lewis J.W., Terman G.W., Gale R.P., Liebeskind J.C. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytolytic activity. Science 1984, 223:188-190.
156. Shi J.M., Lai S.G., Xu C.J., Duan G.L., Li D. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats. Acta Pharmacol. Sin. 2004, 25:996-999.
157. Sinclair M.D. A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice. Can. Vet. J. 2003, 44:885-897.
158. Sladky K.K., Krugner-Higby L., Meek-Walker E., Heath T.D., Paul-Murphy J. Serum concentrations and analgesic effects of liposome-encapsulated and standard butorphanol tartrate in parrots. Am. J. Vet. Res. 2006, 67:775-781.
159. Smith L.J., Krugner-Higby L., Clark M., Wendland A., Heath T.D. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain. Comp. Med. 2003, 53:290-297.
160. Smith L.J., Krugner-Higby L., Trepanier L.A., Flaska D.E., Joers V., Heath T.D. Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposomeencapsulated formulation in dogs. J. Vet. Pharmacol. Ther. 2004, 27:369-372.
161. Smith R.J. Nonsteroid anti-inflammatory agents: Regulators of the phagocytic secretion of lysosomal enzymes from guinea-pig neutrophils. J. Pharmacol. Exp. Ther. 1978, 207:618-629.
162. Snipes J.A., Kis B., Shelness G.S., Hewett J.A., Busija D.W. Cloning and characterization of cyclooxygenase-lb (putative cyclooxygenase-3) in rat. J. Pharmacol. Exp. Ther. 2005, 313:668-676.
163. Speth R.C., Smith M.S., Brogan R.S. Regarding the inadvisability of administering postoperative analgesics in the drinking water of rats ( Rattus norvegicus). Contemp. Top. Lab. Anim. Sci. 2001, 40(6):15-17.
164. Stewart L.S.A., Martin W.J. Evaluation ofpostoperative analgesia in a rat model of incisional pain. Contemp. Top. Lab. Anim. Sci. 2003, 42(1):28-34.
165. Streppa H.K., Jones C.J., Budsberg S.C. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. Am. J. Yet. Res. 2002, 63:91-94.
166. Strigo I.A., Duncan G.H., Bushnell M.C., et al. The effects ofracemic ketamine on painful stimulation of skin and viscera in human subjects. Pain 2005, 113:255-264.
167. Suyama H., Kawamoto M., Gaus S., Yuge O. Effect of etodolac, a COX-2 inhibitor, on neuropathic pain in a rat model. Brain Res. 2004, 4:144-150.
168. Szabo I., Rojivin M., Bussiere J.L., Eisenstein T.K., Adler M.W., Rogers T.S. Suppression of peritoneal macrophage phagocytosis ofCandida albicans by opioids. J. Pharmacol. Exp. Ther. 1993, 267:703-706.
169. Tachibana M., Inoue N., Yoshida E., Matsui M., Ukai Y., Yano J. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats. Pharmacology 2003, 68:96-104.
170. Taylor P.M., Delatour P., Landoni F.M., Deal C., Pickett C., Shojaee F., Aliabadi R., Foot R., Lees P. Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. Res. Vet. Sci. 1996, 60:144-151.
171. Taylor P.M., Robertson S.A., Dixon M.J., Ruprah M., Sear J.W., Lascelles B.D., Waters C., Bloomfield M. Morphine, pethidine and buprenorphine disposition in the cat. J. Vet. Pharmacol. Ther. 2001, 24:391-398.
172. Terner J.M., Lomas L.M., Smith E.S., Barrett A.C., Picker M.J. Pharmacogenetic analysis of sex differences in opioid antinociception in rats. Pain 2003, 106:381-391.
173. Väisänen M.A.M., Vainio O.M., Raekallio M.R., Hietanen H., Huikuri H.V. Results of 24-hour ambulatory electrocardiography in dogs undergoing ovariohysterectomy following premedication with medetomidine or acepromazine. J. Am. Vet. Med. Assoc. 2005, 226:738-745.
174. Valverde C.R., Mama K.R., Kollias-Baker C., Steffey E.P., Baggot J.D. Pharmacokinetics and cardiopulmonary effects of fentanyl in isoflurane-anesthetized rhesus monkeys ( Macaca mulatto). Am. J. Vet. Res. 2000, 61:931-934.
175. Vonderhaar M.A., Salisbury S.K. Gastroduodenal ulceration associated with flunixin meglumine administration in three dogs. J. Am. Vet. Med. Assoc. 1993, 203:92-95.
176. Warner T.D., Giuliano F., Vojnovic I., Bukasa A., Mitchell J.A., Vane J.R. Nonsteroidal drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestional toxicity: A full in vitro analysis. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7563-7568.
177. Warner T.D., Mitchell J.A. Cyclooxygenases: New forms, new inhibitors, and lessons from the clinic. FASEB J. 2004, 18:790-804.
178. Welsh E.M., Baxter P., Nolan A.M. Pharmacokinetics of carprofen administered intravenously to sheep. Res. Vet. Sci. 1992, 53:264-266.
179. Wilson D., Pettifer G.R., Hosgood G. Effect of transdermally administered fentanyl on minimum alveolar concentration of isoflurane in normothermic and hypothermic dogs. J. Am. Yet. Med. Assoc. 2006, 228:1042-1046.
180. Woolf C.J., Bennett G.J., Doherty M., et al. Towards a mechanism-based classification of pain?. Pain 1998, 77:227-229.
181. Yamashita K., Tsubakishita S., Futaok S., Ueda I., Hamaguchi H., Seno T., Katoh S., Izumisawa Y., Kotani T., Muir W.W. Cardiovascular effects of medetomidine, detomidine and xylazine in horses. J. Vet. Med. Sci. 2000, 62:1025-1032.
182. Yasui H., Yamaoka K., Nakagawa T. Moment analysis of stereoselective enterohepatic circulation and unidirectional chiral inversion of ketoprofen enantiomers in rat. J. Pharm. Sci. 1996, 85:580-585.
183. Yu S., Zhang X., Sun Y., Peng Y., Johnson J., Mandrell T., Shukla A.J., Laizure S.C. Pharmacokinetics of buprenorphine after intravenous administration in the mouse. J. Am. Assoc. Lab. Anim. Sci. 2006, 45(3):12-16.